August 13, 2025 a 08:38 pm
TMO: Analysts Ratings - Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc., a global leader in life sciences solutions, has been consistently receiving favorable analyst ratings with a majority leaning towards 'Strong Buy' and 'Buy'. Their robust market position is supported by innovative products and expansive service offerings across diverse sectors. This strong footing is reflected in the analyst sentiment that remains largely positive with minimal indication of sell recommendations.
Historical Stock Grades
August 2025 represents a robust sentiment towards Thermo Fisher, with significant strength in 'Buy' and 'Strong Buy' ratings.
| Recommendation | Count | Score |
|---|---|---|
| Strong Buy | 8 | |
| Buy | 15 | |
| Hold | 7 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
- Over recent months, 'Strong Buy' and 'Buy' recommendations have maintained dominance in the ratings.
- While the number of 'Buy' ratings saw minor fluctuations, the overall sentiment remains optimistic.
- A notable increase in 'Hold' ratings suggests a cautious but positive appraisal influenced potentially by market conditions.
Percentage Trends
- Currently, 'Strong Buy' constitutes approximately 29% of all ratings, whereas 'Buy' holds a substantial 54%.
- Comparative analysis of previous months shows a trend toward maintaining strong buy confidence even amidst market uncertainties.
- Despite slight shifts, the absence of 'Sell' recommendations underscores a steady confidence level in the company's prospects.
Latest Analyst Recommendations
Recent analyst recommendations indicate a consistent outlook with no immediate shifts in market perception.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-07-24 | Outperform | Outperform | Raymond James |
| 2025-07-24 | Overweight | Overweight | Wells Fargo |
| 2025-07-24 | Neutral | Neutral | UBS |
| 2025-07-24 | Equal Weight | Equal Weight | Barclays |
| 2025-07-24 | Outperform | Outperform | Baird |
Analyst Recommendations with Change of Opinion
The sentiment shows minor shifts, indicating varying degrees of confidence and caution among analysts.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-07-11 | Sector Outperform | Sector Perform | Scotiabank |
| 2025-07-09 | Neutral | Buy | UBS |
| 2024-01-24 | Equal Weight | Overweight | Barclays |
| 2024-01-08 | Market Perform | Outperform | Bernstein |
| 2023-10-26 | Sector Weight | Overweight | Keybanc |
Interpretation
The overall sentiment towards Thermo Fisher Scientific Inc. remains largely positive, supported by a strong preference for 'Buy' and 'Strong Buy' ratings. While some analysts exhibit caution with an increase in 'Hold' recommendations, there are no immediate signs of declining trust. The stable nature of these ratings suggests a balanced market perception, reflecting confidence in the company's continued growth and strategic initiatives.
Conclusion
Thermo Fisher Scientific Inc. enjoys a stable and predominantly positive analyst sentiment, with strong confidence in its market position and future growth potential. While a steady increase in 'Hold' ratings points towards some emerging caution, the lack of 'Sell' recommendations and consistent 'Buy' support signify robust market trust. Evaluating these trends, analysts appear to be cautiously optimistic, balancing potential short-term market fluctuations against long-term growth projections.